Smith M D, Triantafillou S, Parker A, Wikaningrum R, Coleman M
Rheumatology Research Unit, Repatriation General Hospital, Daw Park, South Australia.
Diagn Mol Pathol. 1997 Feb;6(1):34-41. doi: 10.1097/00019606-199702000-00006.
Current research into cytokine production in tissue sections relies on the detection of cytokine proteins using a variety of immunohistochemical methods. The disadvantages of this technique are that precise localization to a particular cell is difficult and it is uncertain whether the cells detected by this method are the origin or target of the cytokine or rather have nonspecifically absorbed the secreted cytokine. This question can be clarified using in situ hybridization, but current techniques are insensitive, poorly localizing, or time consuming. Biotin-labeled riboprobes were generated from cDNA fragments sandwiched between two RNA polymerase promoters (SP6 and T7 RNA polymerases) using a commercial riboprobe generation kit containing biotin-labeled UTP. The in situ hybridization technique was used to demonstrate cytokine mRNA in a range of tissues containing an inflammatory infiltrate and with a range of cytokine probes. This technique of in situ hybridization was combined with immunohistochemistry using an immunoalkaline phosphatase technique to show the powerful combination of these two techniques. The biotin-labeled riboprobes were sensitive enough to detect a range of cytokine mRNAs in a variety of tissue sections. The technique can be completed over a 24-h period and produces a stable color product that can be stored for long periods and can be quantitated using image analysis techniques. This technique was performed on paraffin-embedded tissue as well as cryosections and allowed for the detection of mRNA in archival tissue. It was also successfully combined with immunohistochemical techniques to determine simultaneously the localization of a cytokine product in particular cell lineages. A nonradioactive method for in situ hybridization using biotin-labeled riboprobes is described; it is capable of detecting mRNA products from a range of genes in a variety of tissue samples. An amplification step in the method enhances the sensitivity to a level that approaches that of radioactive methods, while maintaining the speed, safety, and simplicity of an immunoperoxidase detection system. The ability to use paraffin-embedded tissue with this method allows for improved tissue architecture and examination of archival tissue. These features should ensure greater use of in situ hybridization techniques in future research studies.
目前对组织切片中细胞因子产生的研究依赖于使用多种免疫组织化学方法检测细胞因子蛋白。该技术的缺点是难以精确确定特定细胞的定位,并且通过这种方法检测到的细胞是细胞因子的来源还是靶细胞,亦或是非特异性吸收了分泌的细胞因子并不确定。使用原位杂交可以阐明这个问题,但目前的技术不敏感、定位不佳或耗时。使用含有生物素标记的UTP的商业核糖探针生成试剂盒,从夹在两个RNA聚合酶启动子(SP6和T7 RNA聚合酶)之间的cDNA片段生成生物素标记的核糖探针。原位杂交技术用于在一系列含有炎性浸润的组织中,使用一系列细胞因子探针来证明细胞因子mRNA。这种原位杂交技术与使用免疫碱性磷酸酶技术进行的免疫组织化学相结合,以展示这两种技术的强大组合。生物素标记的核糖探针足够灵敏,能够在各种组织切片中检测到一系列细胞因子mRNA。该技术可以在24小时内完成,并产生一种稳定的显色产物,该产物可以长期保存,并可以使用图像分析技术进行定量。该技术可在石蜡包埋组织以及冷冻切片上进行,并可检测存档组织中的mRNA。它还成功地与免疫组织化学技术相结合,以同时确定特定细胞谱系中细胞因子产物的定位情况。本文描述了一种使用生物素标记的核糖探针进行原位杂交的非放射性方法;它能够在各种组织样本中检测来自一系列基因的mRNA产物。该方法中的一个扩增步骤将灵敏度提高到接近放射性方法的水平,同时保持免疫过氧化物酶检测系统的速度、安全性和简便性。使用该方法处理石蜡包埋组织的能力可改善组织结构并对存档组织进行检查。这些特性应能确保原位杂交技术在未来的研究中得到更广泛的应用。